Microsert is a leading brand in the field of ocular drug release, specializing in the development of an innovative implantable device called the BlueDOT. The BlueDOT is a reservoir-type device that offers long-lasting drug release for the treatment of Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). What sets Microsert apart is their commitment to convenience and patient comfort.

The device can be easily implanted in a private office procedure without the need for incisions. Additionally, the implant is highly versatile, allowing for customization of release profiles to suit individual patient needs. Remarkably, the BlueDOT can be refilled within two years after implantation, ensuring continuous and effective drug delivery.

Microsert's breakthrough technology has gained recognition and support, receiving funding from the European Union's Horizon 2020 research and innovation program. Experience cutting-edge ocular drug delivery with Microsert's advanced and reliable solutions. Contact Microsert today to learn more about their game-changing products and services